Shandong Teamgene Technology Co., Ltd. Stock

Equities

603151

CNE100005NN0

Fishing & Farming

End-of-day quote Shanghai S.E. 06:00:00 2024-05-19 pm EDT 5-day change 1st Jan Change
14.19 CNY +3.28% Intraday chart for Shandong Teamgene Technology Co., Ltd. -0.14% -5.96%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 2.18B 301M Sales 2025 * 2.5B 346M Capitalization 2.38B 330M
Net income 2024 * 123M 17M Net income 2025 * 173M 23.92M EV / Sales 2024 * 1.09 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.95 x
P/E ratio 2024 *
19.4 x
P/E ratio 2025 *
13.8 x
Employees 614
Yield 2024 *
1.41%
Yield 2025 *
1.06%
Free-Float 27.42%
More Fundamentals * Assessed data
Dynamic Chart
Shandong Teamgene Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shandong Teamgene Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shandong Teamgene Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shandong Teamgene Technology Co., Ltd.(SHSE:603151) added to Shanghai Stock Exchange Composite Index CI
Shandong Teamgene Technology Co., Ltd.(SHSE:603151) added to Shanghai Stock Exchange A Share Index CI
Certain A Shares of Shandong Teamgene Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 19-OCT-2023. CI
Shandong Teamgene Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Binzhou Huijia Biotechnology Co., Ltd. announced that it expects to receive CNY 113 million in funding from Shandong Teamgene Technology Co., Ltd., Qingdao Xiaozhi Biotechnology Co., Ltd. CI
Shandong Teamgene Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shandong Teamgene Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanxi Teamgene Biological announced that it expects to receive CNY 50 million in funding from Shandong Teamgene Technology Co., Ltd. CI
Shanxi Teamgene Biological announced that it expects to receive funding from Shandong Teamgene Technology Co., Ltd. CI
Yunnan Teamgene Feed Co., Ltd. announced that it expects to receive CNY 110 million in funding from Shandong Teamgene Technology Co., Ltd. CI
Shandong Teamgene Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shandong Teamgene Technology Co., Ltd. has completed an IPO in the amount of CNY 753.9 million. CI
More news
1 day+3.28%
1 week-0.14%
Current month+5.50%
1 month+22.22%
3 months+42.47%
6 months-7.92%
Current year-5.96%
More quotes
1 week
13.54
Extreme 13.54
14.49
1 month
11.17
Extreme 11.17
14.98
Current year
8.31
Extreme 8.31
15.87
1 year
8.31
Extreme 8.31
18.25
3 years
8.31
Extreme 8.31
26.37
5 years
8.31
Extreme 8.31
26.37
10 years
8.31
Extreme 8.31
26.37
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 07-04-30
Chairman 38 20-07-17
Director of Finance/CFO 38 20-07-17
Members of the board TitleAgeSince
Director/Board Member 45 20-07-17
Chief Executive Officer 49 07-04-30
Director/Board Member 61 20-07-17
More insiders
Date Price Change Volume
24-05-20 14.19 +3.28% 1,888,900
24-05-17 13.74 +0.59% 1,541,276
24-05-16 13.66 -0.07% 1,482,900
24-05-15 13.67 -5.53% 2,682,125
24-05-14 14.47 +1.83% 1,434,400

End-of-day quote Shanghai S.E., May 19, 2024

More quotes
Shandong Teamgene Technology Co Ltd is a China-based company mainly engaged in the research and development, production and sales of pig feed. The Company's main businesses include the production of specialized feeds for modern farms. The Company's main products include swine batches, swine concentrates, swine premixes and other feeds, mainly including egg premixes and meat ruminant feeds. The Company mainly operates in the domestic market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
14.19 CNY
Average target price
18 CNY
Spread / Average Target
+26.85%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603151 Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW